CZD 3.13% 9.3¢ calzada limited

Ann: PolyNovo Concludes Recruitment for VAC Trial, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,346 Posts.
    lightbulb Created with Sketch. 48
    re: Ann: PolyNovo Concludes Recruitment for V... main points from http://www.metabolic.com.au/
    4 February 2013
    PolyNovo Concludes Recruitment for the NovoSorb™ VAC Clinical Trial
    ? Final patient recruited in the NovoSorb™ Vacuum Assisted Closure (VAC) Clinical Study,
    ? Results expected within 75 days,
    ? Positive results will support PolyNovo’s application for Marketing Approval in the United States
    of America (via a 510(k) Clearance Pathway),
    ? PolyNovo expects to file for 510(k) clearance in the USA in Q3, 2013.
 
watchlist Created with Sketch. Add CZD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.